Paul J. Tiseo
Hoofd Techniek/Wetenschap/O&O bij COGNITION THERAPEUTICS, INC.
Profiel
Paul J.
Tiseo is currently the Vice President-Clinical Development at Cognition Therapeutics, Inc. Prior to this, he worked as the Executive Director-Clinical Development at Centrexion Therapeutics Corp.
He completed his undergraduate degree at Stony Brook University and his doctorate at Lewis Katz School of Medicine.
Actieve functies van Paul J. Tiseo
| Bedrijven | Functie | Begin |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 11-10-2022 |
Eerdere bekende functies van Paul J. Tiseo
| Bedrijven | Functie | Einde |
|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
Opleiding van Paul J. Tiseo
| Stony Brook University | Undergraduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
